Home › Companies › Mereo Biopharma Group PLC

Mereo Biopharma Group PLC (MREO) proxy voting records

How asset managers voted at Mereo Biopharma Group PLC’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

TickerMREO
CUSIP issuer number589492
SEC CIK1719714

Recent shareholder votes

May 13, 2025 annual meeting (2024-2025 proxy season): 6 items in Mereo Biopharma Group PLC's official results (Form 8-K, filed May 14, 2025); lowest support 85% of votes cast (Resolution 9 That Michael Wyzga be re-appointed as a director…). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Season	Filed as	Ballot items	Asset managers
2024-2025	MEREO BIOPHARMA GROUP PLC	10	61

Earlier seasons list this company under the name MEREO BIOPHARMA GROUP PLC, as its holders filed it.

Explore Mereo Biopharma Group PLC in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on November 6, 2026. This page is rebuilt weekly; built November 9, 2026.